In the race to find treatments for COVID-19, researchers say a class of long-used drugs called interferons looks promising as part of a regimen to speed recovery.
faster. It also seemed to reduce certain inflammatory proteins linked to severe COVID-19 complications.Frontiers in Immunology.
To Fish, either interferon-alfa or -beta could be effective in managing COVID-19. But, she argued, researchers should focus on studying the drugs as solo treatments, unlike the recent"We need to stop combining them with other stuff, because it just muddies the issue," Fish said."You can't tell which drug is effective."
As for interferon-alfa as a solo treatment, the experience of the Wuhan patients leaves open questions, according to Moore. Interferons do have side effects, including flu-like symptoms, nausea and weight loss. Both Fish and Moore said those side effects are significant when the drug is taken for the long haul: For a person with chronic hepatitis C who feels healthy, the side effects are hard to tolerate.
Patients will get a single injection of the drug, which lasts in the body for a week, said study co-leader Dr. Upinder Singh, a professor of infectious diseases.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
This small Texas hospital is finding ways to save COVID-19 patientsA Houston hospital isn't just battling the coronavirus. It faces patients who, convinced they're not infected, leave before treatment is finished.
Weiterlesen »
Vogue and Amazon Just Launched a Storefront That Supports Small Fashion Businesses Affected by COVID-19'Vogue' and Amazon Fashion launched a digital storefront on Amazon that features a range of pieces from 20 small and medium-sized designers
Weiterlesen »
Abbott's fast Covid-19 test may miss too many cases, NYU study findsThe Covid-19 diagnostic test being used by the White House frequently misses cases of the virus, a new study suggests
Weiterlesen »
Convalescent plasma is safe to treat COVID-19: nationwide studyThe experimental therapy involves transfusing the antibody-rich blood serum of recovered COVID-19 patients into people who are battling the coronavirus.
Weiterlesen »
Kidney injury seen in more than a third of hospitalized COVID-19 patients: U.S. studyOver a third of patients treated for COVID-19 in a large New York medical system developed acute kidney injury, and nearly 15% required dialysis, U.S. researchers reported on Thursday.
Weiterlesen »